ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2084

Predictors of Change in Physical Activity Level Among Veterans with Knee Osteoarthritis in a Behaviorally Designed Incentive Program

Criswell Lavery1, Ori Needleman1, Bryant England2, Katherine Wysham3, Mercedes Quinones4, Marianna Olave5, Sarah Wetzel6, Hannah Brubeck7, Rachel Gillcrist8, Natalie Keller9, Kimberly Hayes10, Bibiana Ateh11, Bridget Kramer2, Rui Xiao1, Kaitian Jin1, Alexis Ogdie12, Daniel K. White13, Tuhina Neogi14, Carla Scanzello1 and Joshua Baker1, 1University of Pennsylvania, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 4Washington DC VA Medical Center, Bethesda, MD, 5Brown University, Philadelphia, PA, 6Drexel University, Pittsburgh, PA, 7VA Puget Sound Health Care System, Seattle, WA, 8Dartmouth College, Lebanon, NH, 9University of Oklahoma, Philadelphia, PA, 10Teachers College, Columbia University, Philadelphia, PA, 11Washington VA Medical Center, Washington, District of Columbia, 12Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Wilmington, DE, 13University of Delaware, Newark, DE, 14Boston University School of Medicine, Boston, MA

Meeting: ACR Convergence 2025

Keywords: exercise, Osteoarthritis, physical activity, Randomized Trial

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2079–2105) Osteoarthritis – Clinical Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Physical activity may help reduce symptoms in adults with knee osteoarthritis (KOA), yet few meet the recommended levels. This analysis identified participant characteristics associated with improvement in physical activity over 28 weeks in a clinical trial setting aimed at testing an incentive program utilizing elements of gamification and social incentivization. We hypothesized that greater self-efficacy (confidence in their ability to exercise) would be a significant predictor of improvements in average daily step counts.

Methods: This was a multi-center randomized controlled trial with a factorial design. The study included 221 participants aged 40-85 years from 4 Veterans Affairs centers with a Kellgren-Lawrence (KL) knee radiograph grade ≥1 and clinical indication for a corticosteroid joint injection. Participants were randomized into either the incentive program or control and then further randomized to receive corticosteroid or lidocaine-only injections. A web-based platform collected daily step counts (from a Fitbit activity monitor) and patient-reported outcomes. Daily step counts were averaged over 2-week periods throughout the 28-week trial. Self-efficacy was measured at enrolment using the Exercise Self-Efficacy Scale. Linear regression incorporating generalized estimating equations was used to evaluate the association of participant characteristics with the change in average daily step counts. Variables associated with the outcome (p< 0.1) in univariate analyses were tested in multivariable models and removed in a backwards selection process to arrive at a final model.

Results: A total of 221 participants were randomized. Mean participant age was 64 years-old and 87% male. Unadjusted associations between participant characteristics and change in average daily steps are shown in Table 1. Individuals with greater self-efficacy for exercise demonstrated significantly greater increases in the average daily step count (Figure 1). This effect was greatest for participants in the highest tertile, whose daily step counts increased about 1145 steps more than those in the lowest tertile (Figure 1). This pattern was observed in both incentive and control arms and was an independent predictor in the multivariable model (Table 2). Patient characteristics associated with less improvement in average daily step count included higher pain scores, worse sleep quality, greater fatigue, kidney disease, and higher BMI. Participants that lived in areas in the highest quartile of Area Deprivation Index (ADI) also failed to improve.

Conclusion: We identified predictors of improvement in physical activity level among patients with KOA in the context of a clinical trial. Higher self-efficacy for exercise was a strong predictor of greater improvement in physical activity levels throughout follow-up. Less improvement was observed among those with greater pain, comorbidity, BMI, fatigue, and among those living in unsafe areas or areas with high ADI. These observations highlight the need to address low self-efficacy and other barriers in order successfully promote exercise in this population.

Supporting image 1Table 1: Factors associated with change in average step counts in univariate models. **Also tested but not significant: smoking status, heart disease, degenerative disc disease, heart failure, depression, employment status.

Supporting image 2Table 2: Factors associated with changes in average step counts in a multivariable model.

Supporting image 3Figure 1. Average change in daily steps (with 95% CI) overall and by incentive group among Veterans with knee osteoarthritis, predicted from univariate linear regression models.


Disclosures: C. Lavery: None; O. Needleman: None; B. England: Boehringer-Ingelheim, 2, 5; K. Wysham: None; M. Quinones: None; M. Olave: None; S. Wetzel: None; H. Brubeck: None; R. Gillcrist: None; N. Keller: None; K. Hayes: None; B. Ateh: None; B. Kramer: None; R. Xiao: None; K. Jin: None; A. Ogdie: AbbVie, 5, Amgen, 5, 11, Bristol Myers Squibb, 5, Celgene, 5, CorEvitas, 2, Eli Lilly, 5, Novartis, 5, 11, Pfizer, 5, 11; D. White: None; T. Neogi: None; C. Scanzello: COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS USING A CD14 INHIBITOR, 10; J. Baker: Amgen, 5.

To cite this abstract in AMA style:

Lavery C, Needleman O, England B, Wysham K, Quinones M, Olave M, Wetzel S, Brubeck H, Gillcrist R, Keller N, Hayes K, Ateh B, Kramer B, Xiao R, Jin K, Ogdie A, White D, Neogi T, Scanzello C, Baker J. Predictors of Change in Physical Activity Level Among Veterans with Knee Osteoarthritis in a Behaviorally Designed Incentive Program [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/predictors-of-change-in-physical-activity-level-among-veterans-with-knee-osteoarthritis-in-a-behaviorally-designed-incentive-program/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-change-in-physical-activity-level-among-veterans-with-knee-osteoarthritis-in-a-behaviorally-designed-incentive-program/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology